BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee J, Phong B, Egloff AM, Kane LP. TIM polymorphisms--genetics and function. Genes Immun 2011;12:595-604. [PMID: 22048452 DOI: 10.1038/gene.2011.75] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Phong B, Kane LP. Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies. F1000Res 2016;5:251. [PMID: 30023044 DOI: 10.12688/f1000research.8132.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Pouladian M, Ganjalikhani-hakemi M, Alsahebfosul F, Homayouni V, Khosravi S, Etemadifar M, Mazrouei F, Salehi R. The +4259A>C polymorphism of TIM-3 but not -1637C>T polymorphism of TIM-1 is associated with Multiple sclerosis in Isfahan population. Multiple Sclerosis and Related Disorders 2017;18:152-6. [DOI: 10.1016/j.msard.2017.09.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Chen L, Qing J, Xiao Y, Huang X, Chi Y, Chen Z. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway. BMC Cancer 2022;22:370. [PMID: 35392845 DOI: 10.1186/s12885-022-09386-7] [Reference Citation Analysis]
4 Boehne C, Behrendt AK, Meyer-Bahlburg A, Boettcher M, Drube S, Kamradt T, Hansen G. Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma. PLoS One 2021;16:e0249605. [PMID: 33822811 DOI: 10.1371/journal.pone.0249605] [Reference Citation Analysis]
5 Wu JL, Zhao J, Zhang HB, Zuo WW, Li Y, Kang S. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer. Gynecol Oncol 2020;159:270-6. [PMID: 32694063 DOI: 10.1016/j.ygyno.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Brooks CR, Yeung MY, Brooks YS, Chen H, Ichimura T, Henderson JM, Bonventre JV. KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation. EMBO J 2015;34:2441-64. [PMID: 26282792 DOI: 10.15252/embj.201489838] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 7.1] [Reference Citation Analysis]
7 Schnell A, Bod L, Madi A, Kuchroo VK. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity. Cell Res 2020;30:285-99. [PMID: 31974523 DOI: 10.1038/s41422-020-0277-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
8 Shen H, Zhang X, Al Hafiz MA, Liang X, Yao Q, Guo M, Xu G, Zhong X, Zhou Q, Zhao H. The Proteins Interacting with Prmt5 in Medaka (Oryzias latipes) Identified by Yeast Two-Hybridization. Protein Pept Lett 2020;27:971-8. [PMID: 32370700 DOI: 10.2174/0929866527666200505213431] [Reference Citation Analysis]
9 Mazrouei F, Ganjalikhani-hakemi M, Salehi R, Alesahebfosoul F, Etemadifar M, Pouladian M, Meshkat R, Nekoueian S, Zarkesh-esfahani H, Ziyaee-ghahnaviyeh M. Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan population. Int J Immunogenet 2016;43:131-4. [DOI: 10.1111/iji.12264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
10 Ding QQ, Chauvin JM, Zarour HM. Targeting novel inhibitory receptors in cancer immunotherapy. Semin Immunol 2020;49:101436. [PMID: 33288379 DOI: 10.1016/j.smim.2020.101436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sharma G, Ohtani H, Kaur G, Naruse TK, Sharma S, Vajpayee M, Kimura A, Mehra N. Status of TIM-1 exon 4 haplotypes and CD4+T cell counts in HIV-1 seroprevalent North Indians. Human Immunology 2013;74:163-5. [DOI: 10.1016/j.humimm.2012.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Soyka MB, van de Veen W, Holzmann D, Akdis M, Akdis CA. Scientific foundations of allergen-specific immunotherapy for allergic disease. Chest 2014;146:1347-57. [PMID: 25367471 DOI: 10.1378/chest.14-0049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
13 Li J, Qiu Y, Li L, Wang J, Cheuk YC, Sang R, Jia Y, Wang J, Zhang Y, Rong R. Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation. Front Med (Lausanne) 2020;7:305. [PMID: 32754604 DOI: 10.3389/fmed.2020.00305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Soyer OU, Akdis M, Ring J, Behrendt H, Crameri R, Lauener R, Akdis CA. Mechanisms of peripheral tolerance to allergens. Allergy. 2013;68:161-170. [PMID: 23253293 DOI: 10.1111/all.12085] [Cited by in Crossref: 91] [Cited by in F6Publishing: 72] [Article Influence: 9.1] [Reference Citation Analysis]
15 Khan A, Bresnick A, Cahill S, Girvin M, Almo S, Quinn R. Advantages of Molecular Weight Identification during Native MS Screening. Planta Med 2018;84:1201-12. [PMID: 29742762 DOI: 10.1055/a-0608-4870] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Tao J, Li L, Fu R, Wang H, Jiang H, Yue L, Zhang W, Liu H, Ruan E, Qu W, Wang G, Wang X, Wu Y, Liu H, Song J, Guan J, Xing L, Shao Z. Elevated TIM3+ hematopoietic stem cells in untreated myelodysplastic syndrome displayed aberrant differentiation, overproliferation and decreased apoptosis. Leukemia Research 2014;38:714-21. [DOI: 10.1016/j.leukres.2014.03.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
17 Mewes C, Alexander T, Büttner B, Hinz J, Alpert A, Popov AF, Ghadimi M, Beißbarth T, Tzvetkov M, Grade M, Quintel M, Bergmann I, Mansur A. TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis. Int J Mol Sci 2020;21:E8318. [PMID: 33171904 DOI: 10.3390/ijms21218318] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kalantari S, Nafar M. A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy. Biomarkers in Medicine 2017;11:781-97. [DOI: 10.2217/bmm-2017-0081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
19 Homayouni V, Khanahmad H, Ganjalikhani-Hakemi M, Behdani M, Ghasemi P, Rezaei A. Stimulation of Camel Polyclonal Antibody against Human T cell Immunoglobulin and Mucin 3. Iran J Biotechnol 2017;15:166-71. [PMID: 29845065 DOI: 10.15171/ijb.1427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
20 Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review. Semin Cancer Biol 2020;64:93-101. [PMID: 31330185 DOI: 10.1016/j.semcancer.2019.06.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
21 Moller-Tank S, Albritton LM, Rennert PD, Maury W. Characterizing functional domains for TIM-mediated enveloped virus entry. J Virol 2014;88:6702-13. [PMID: 24696470 DOI: 10.1128/JVI.00300-14] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
22 Fang X, Xu W, Pan H, Leng R, Ye D. Novel insights into Tim-4 function in autoimmune diseases. Autoimmunity 2014;48:189-95. [DOI: 10.3109/08916934.2014.983266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
23 Sinha S, Singh J, Jindal SK. Protective association of TIM1-1454G>a polymorphism with asthma in a North Indian population. Lung 2015;193:31-8. [PMID: 25331534 DOI: 10.1007/s00408-014-9653-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Wagner M, Jasek M, Karabon L. Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk. Front Immunol 2020;11:606721. [PMID: 33519815 DOI: 10.3389/fimmu.2020.606721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ataei M, Behfarjam F, Jadali Z. TIM-3 genetic variants and risk of Behçet disease in the Iranian population. An Bras Dermatol 2019;94:429-33. [PMID: 31644615 DOI: 10.1590/abd1806-4841.20198022] [Reference Citation Analysis]
26 Tocheva AS, Mor A. Checkpoint Inhibitors: Applications for Autoimmunity. Curr Allergy Asthma Rep 2017;17:72. [PMID: 28956259 DOI: 10.1007/s11882-017-0740-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
27 Roth CG, Garner K, Eyck ST, Boyiadzis M, Kane LP, Craig FE. TIM3 expression by leukemic and non-leukemic myeloblasts. Cytometry B Clin Cytom 2013;84:167-72. [PMID: 23554257 DOI: 10.1002/cyto.b.21080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
28 Cai XZ, Huang WY, Qiao Y, Chen Y, Du SY, Chen D, Yu S, Liu N, Dou LY, Jiang Y. Downregulation of TIM-3 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Braz J Med Biol Res 2015;48:77-82. [PMID: 25493386 DOI: 10.1590/1414-431x20143701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
29 Acharya N, Sabatos-Peyton C, Anderson AC. Tim-3 finds its place in the cancer immunotherapy landscape.J Immunother Cancer. 2020;8. [PMID: 32601081 DOI: 10.1136/jitc-2020-000911] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 40.0] [Reference Citation Analysis]
30 Fang H, Yuan C, Gu X, Chen Q, Huang D, Li H, Sun M. Association between TIM-3 polymorphisms and cancer risk: a meta-analysis. Ann Transl Med 2019;7:550. [PMID: 32133384 DOI: 10.21037/atm.2019.09.101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]